2.4800
+0.3000
+(13.76%)
As of 9:38:57 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-7,304.0000
-9,974.0000
-10,561.0000
-10,366.0000
-12,357.0000
Investing Cash Flow
-5.0000
-12.0000
-70.0000
-116.0000
-32.0000
Financing Cash Flow
10,404.0000
3,726.0000
5,122.0000
1,947.0000
28,211.0000
End Cash Position
4,930.0000
1,103.0000
7,363.0000
12,872.0000
21,407.0000
Capital Expenditure
-5.0000
-12.0000
-70.0000
-116.0000
-32.0000
Issuance of Capital Stock
11,859.0000
4,388.0000
5,540.0000
2,001.0000
30,500.0000
Issuance of Debt
--
--
--
--
506.0000
Free Cash Flow
-7,309.0000
-9,986.0000
-10,631.0000
-10,482.0000
-12,389.0000
12/31/2020 - 11/13/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADIL Adial Pharmaceuticals, Inc.
0.9600
-1.85%
XRTX XORTX Therapeutics Inc.
0.9000
-1.10%
LIXT Lixte Biotechnology Holdings, Inc.
2.4042
+0.17%
AVTE Aerovate Therapeutics, Inc.
2.5700
-0.77%
PSTV Plus Therapeutics, Inc.
1.2200
+0.83%
KZR Kezar Life Sciences, Inc.
6.40
+0.95%
GDTC CytoMed Therapeutics Limited
2.6100
+1.95%
SABS SAB Biotherapeutics, Inc.
3.9791
-2.95%
BOLD Boundless Bio, Inc.
2.4000
-0.41%
DRMA Dermata Therapeutics, Inc.
1.1600
-0.85%